Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Burning skin; Painful arm; This non-serious case was reported by a consumer and described the occurrence of burning skin in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included bupropion hydrochloride (Wellbutrin Xl). On 05-JUL-2024, the patient received Shingrix. On 05-JUL-2024, less than a day after receiving Shingrix, the patient experienced burning skin (Verbatim: Burning skin) and pain in arm (Verbatim: Painful arm). On 15-JUL-2024, the outcome of the burning skin was resolved (duration 10 days) and the outcome of the pain in arm was resolved. It was unknown if the reporter considered the burning skin and pain in arm to be related to Shingrix. It was unknown if the company considered the burning skin and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 27-JAN-2025 The reporter reported that the Shingrix was known to have injection pain and redness more than other types of injection. Please take the tylenol or ibuprofen as needed, especially the same night. The reporter was 20 and more year consultant with GSK and he/she know the difference between side effects and an adverse events.
WELLBUTRIN XL